MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and Cachexia
Dual-contrast microCT provides high-resolution, whole-body, noninvasive imaging in orthotopic murine PDAC models, enabling simultaneous tracking of tumor growth, metastasis, and skeletal muscle wasting, offering a clinically relevant, translational imaging platform.
Authors
- Katherine R. Pelz (ORCID: https://orcid.org/0000-0003-2169-0613)
- Samuel D. Newton (ORCID: https://orcid.org/0009-0002-3926-7709)
- Patrick J. Worth (ORCID: https://orcid.org/0000-0001-9600-0678)
- Teresa A. Zimmers (ORCID: https://orcid.org/0000-0001-7872-0540)
- Jonathan R. Brody (ORCID: https://orcid.org/0000-0003-3680-3270)
- Rosalie C. Sears (ORCID: https://orcid.org/0000-0003-1558-2413)
- Melissa Cunningham (ORCID: https://orcid.org/0009-0003-2851-9138)
- P Villanueva Jimenez (ORCID: https://orcid.org/0009-0008-1133-802X)
- Colin J. Daniel (ORCID: https://orcid.org/0009-0008-1915-3660)
Institutions
- Oregon Health & Science University (US)
Publication Details
- Journal
- Cancer Research Communications
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1158/2767-9764.crc-25-0414
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- Oregon Health and Science University
- National Institutes of Health
- Knight Cancer Institute, Oregon Health and Science University